IRIS Accounts Production v24.3.0.553 06560722 director 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary share 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh065607222023-03-31065607222024-03-31065607222023-04-012024-03-31065607222022-03-31065607222022-04-012023-03-31065607222023-03-3106560722ns15:EnglandWales2023-04-012024-03-3106560722ns14:PoundSterling2023-04-012024-03-3106560722ns10:Director12023-04-012024-03-3106560722ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106560722ns10:SmallEntities2023-04-012024-03-3106560722ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3106560722ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106560722ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106560722ns10:FullAccounts2023-04-012024-03-3106560722ns10:OrdinaryShareClass12023-04-012024-03-3106560722ns10:RegisteredOffice2023-04-012024-03-3106560722ns5:CurrentFinancialInstruments2024-03-3106560722ns5:CurrentFinancialInstruments2023-03-3106560722ns5:ShareCapital2024-03-3106560722ns5:ShareCapital2023-03-3106560722ns5:RetainedEarningsAccumulatedLosses2024-03-3106560722ns5:RetainedEarningsAccumulatedLosses2023-03-3106560722ns5:PlantMachinery2023-03-3106560722ns5:FurnitureFittings2023-03-3106560722ns5:ComputerEquipment2023-03-3106560722ns5:PlantMachinery2023-04-012024-03-3106560722ns5:FurnitureFittings2023-04-012024-03-3106560722ns5:ComputerEquipment2023-04-012024-03-3106560722ns5:PlantMachinery2024-03-3106560722ns5:FurnitureFittings2024-03-3106560722ns5:ComputerEquipment2024-03-3106560722ns5:PlantMachinery2023-03-3106560722ns5:FurnitureFittings2023-03-3106560722ns5:ComputerEquipment2023-03-3106560722ns5:CurrentFinancialInstruments2023-04-012024-03-3106560722ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 06560722 (England and Wales)










Ephedra Healthcare Limited

Unaudited Financial Statements

for the Year Ended 31 March 2024






Ephedra Healthcare Limited (Registered number: 06560722)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Ephedra Healthcare Limited

Company Information
for the Year Ended 31 March 2024







DIRECTOR: Dr V Tangang





REGISTERED OFFICE: Suite 3, Middlesex House
Rutherford Close
Stevenage
Hertfordshire
SG1 2EF





BUSINESS ADDRESS: C/o Garden City Practice
Birdcroft Road
Welwyn Garden City
Hertfordshire
AL8 6EH





REGISTERED NUMBER: 06560722 (England and Wales)





ACCOUNTANTS: Baker Watkin Accounting Ltd
Chartered Accountants
Middlesex House
Rutherford Close
Stevenage
Hertfordshire
SG1 2EF

Ephedra Healthcare Limited (Registered number: 06560722)

Balance Sheet
31 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 3 16,350 22,903

CURRENT ASSETS
Stocks 9,068 6,475
Debtors 4 457,086 389,494
Prepayments and accrued income 47,606 106,215
Cash at bank 721,884 720,135
1,235,644 1,222,319
CREDITORS
Amounts falling due within one year 5 (358,286 ) (321,755 )
NET CURRENT ASSETS 877,358 900,564
TOTAL ASSETS LESS CURRENT
LIABILITIES

893,708

923,467

PROVISIONS FOR LIABILITIES (3,409 ) (4,351 )
NET ASSETS 890,299 919,116

CAPITAL AND RESERVES
Called up share capital 6 1,089 1,089
Profit and loss reserves 889,210 918,027
SHAREHOLDERS' FUNDS 890,299 919,116

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Ephedra Healthcare Limited (Registered number: 06560722)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 November 2024 and were signed by:





Dr V Tangang - Director


Ephedra Healthcare Limited (Registered number: 06560722)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. ACCOUNTING POLICIES

COMPANY INFORMATION
Ephedra Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Suite 3 Middlesex House, Rutherford Close, Stevenage, Hertfordshire, SG1 2EF.

ACCOUNTING CONVENTION
These financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

TURNOVER
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business. As a provider of medical services the company's activities are outside the scope of VAT.

Revenue from the supply of medical services is recognised by reference to the date of delivery and the financial year to which the funding relates.

TANGIBLE FIXED ASSETS
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of
depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over
their useful lives on the following bases:

Medical equipment 20% straight line
Fixtures and office equipment 20% straight line
Computer equipment 33.3% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

IMPAIRMENT OF FIXED ASSETS
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Ephedra Healthcare Limited (Registered number: 06560722)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

1. ACCOUNTING POLICIES - continued

IMPAIRMENT OF FIXED ASSETS- CONTINUE
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

STOCK
Stocks of prescribing drugs and medical supplies are stated at cost plus overheads incurred in bringing the stocks to their present location.

Stocks of drugs for prescribing to patients and medical supplies are measured at the lower of replacement cost and cost, adjusted where applicable for any potential obsolescence.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated utilization value is recognised as an impairment loss in the profit and loss account.

CASH AND CASH EQUIVALENTS
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

BASIC FINANCIAL ASSETS
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.



Ephedra Healthcare Limited (Registered number: 06560722)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

1. ACCOUNTING POLICIES - continued



CLASSIFICATION OF FINANCIAL LIABILITIES
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BASIC FINANCIAL LIABILITIES
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

EQUITY INSTRUMENTS
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

TAXATION
The tax expense represents the sum of the tax currently payable and deferred tax.

CURRENT TAX
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

DEFERRED TAX
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.




Ephedra Healthcare Limited (Registered number: 06560722)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

1. ACCOUNTING POLICIES - continued






EMPLOYEE BENEFITS
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

RETIREMENT BENEFITS
As an NHS employer, staff are eligible for membership of the NHS Superannuation Scheme. Employer contributions are charged to the profit and loss account in the year they are payable.

LEASES
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 44 (2023 - 38 ) .

3. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2023
and 31 March 2024 21,048 20,944 21,691 63,683
DEPRECIATION
At 1 April 2023 9,273 11,609 19,898 40,780
Charge for year 2,505 2,876 1,172 6,553
At 31 March 2024 11,778 14,485 21,070 47,333
NET BOOK VALUE
At 31 March 2024 9,270 6,459 621 16,350
At 31 March 2023 11,775 9,335 1,793 22,903

Ephedra Healthcare Limited (Registered number: 06560722)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 457,086 389,494

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 163,992 156,363
Corporation tax 101,172 65,765
Other tax and social security 32,722 31,890
Other creditors 38,545 53,329
Accruals and deferred income 21,855 14,408
358,286 321,755

A debenture was created on 24 March 2009 providing security to the company's bankers for loan and overdraft facilities made available to the company. At 31 March 2024 the balance owing to the bank on these facilities amounted to £Nil (2023: £Nil).

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
108,856 Ordinary share 1p 1,089 1,089